Coloplast A/S Class B CLPBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLPBF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $126.05
- Day Range
- $125.85–127.91
- 52-Week Range
- $99.78–145.05
- Bid/Ask
- $86.59 / $38,130.10
- Market Cap
- $28.76 Bil
- Volume/Avg
- 715 / 1,207
Key Statistics
- Price/Earnings (Normalized)
- 39.92
- Price/Sales
- 7.65
- Dividend Yield (Trailing)
- 2.38%
- Dividend Yield (Forward)
- 2.38%
- Total Yield
- 2.41%
Company Profile
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 15,751
- Website
- https://www.coloplast.com
Competitors
Valuation
|
Metric
|
CLPBF
|
CTEC
|
BSX
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.92 | 24.57 | 33.23 |
Price/Book Value | 12.81 | 4.41 | 5.18 |
Price/Sales | 7.65 | 3.40 | 7.00 |
Price/Cash Flow | 31.72 | 19.52 | 30.45 |
Price/Earnings
CLPBF
CTEC
BSX
Financial Strength
|
Metric
|
CLPBF
|
CTEC
|
BSX
|
|---|---|---|---|
Quick Ratio | 0.35 | 0.79 | 0.63 |
Current Ratio | 0.53 | 1.62 | 1.32 |
Interest Coverage | 9.20 | 3.21 | 8.41 |
Quick Ratio
CLPBF
CTEC
BSX
Profitability
|
Metric
|
CLPBF
|
CTEC
|
BSX
|
|---|---|---|---|
Return on Assets (Normalized) | 12.14% | 7.44% | 8.92% |
Return on Equity (Normalized) | 47.39% | 16.69% | 16.33% |
Return on Invested Capital (Normalized) | 16.96% | 10.90% | 11.43% |
Return on Assets
CLPBF
CTEC
BSX
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Gjskpmfd | Hgz | $132.6 Bil | |
BDX
| Becton Dickinson & Co | Skkcftkxg | Xfyqhpl | $67.9 Bil | |
ALC
| Alcon Inc | Rrxffhhyh | Tsbrfmr | $38.9 Bil | |
CLPBY
| Coloplast A/S ADR | Xsckcmfls | Nvfs | $29.3 Bil | |
WST
| West Pharmaceutical Services Inc | Nmjfpnkp | Dtdz | $27.8 Bil | |
RMD
| ResMed Inc | Txprmhlvh | Ywjzk | $25.6 Bil | |
BAX
| Baxter International Inc | Jfcfbyt | Klrmdvv | $20.1 Bil | |
COO
| The Cooper Companies Inc | Vysnffjp | Cnsbvb | $18.0 Bil | |
HOLX
| Hologic Inc | Mfpjgdzd | Fyfswjz | $17.6 Bil | |
TFX
| Teleflex Inc | Why | Zdbz | $9.8 Bil |